论文部分内容阅读
目的:探究阿德福韦酯与丹参片联合治疗乙型肝炎纤维化的临床效果。方法:于我院选取2012年12月至2013年12月收治86例慢性乙型肝炎肝纤维化患者,按照随机分配法将所有患者分为43例观察组和43例参照组,给予参照组患者阿德福韦酯治疗,观察组患者采用阿德福韦酯与丹参片联合治疗,两组患者均进行一年/疗程治疗,观察对比两组患者治疗后的效果。结果:经过治疗后,观察组患者的脾门厚度(32.5±0.5)mm明显低于参照组(45.5±0.5)mm,肝功能指标、血清指标、肝纤维化指标均优于参照组,两组患者差异显著。结论:采用阿德福韦酯与丹参片联合治疗乙型肝炎肝纤维化的临床效果显著,具有临床推广应用意义。
Objective: To investigate the clinical effect of adefovir dipivoxil combined with radix salviae miltiorrhizae in the treatment of hepatitis B fibrosis. Methods: Totally 86 patients with chronic hepatitis B liver fibrosis were enrolled in our hospital from December 2012 to December 2013. All patients were divided into observation group (43 cases) and reference group (43 cases) according to the random distribution method. Patients in the reference group Adefovir dipivoxil treatment, observation group patients treated with adefovir dipivoxil and Salvia tablets, both patients were treated for one year / course of treatment were observed and compared two groups of patients after treatment. Results: After treatment, the spleen door thickness (32.5 ± 0.5) mm in the observation group was significantly lower than that in the reference group (45.5 ± 0.5) mm, liver function index, serum index and liver fibrosis index were better than the reference group, two groups Patients significantly different. Conclusion: Adefovir dipivoxil and Salvia tablets combined treatment of hepatitis B liver fibrosis clinical effect is significant, with clinical application.